“Canada cannot act as a drugstore for the United States,” says academic

In this editorial, which was published by the Fraser Institute on June 13, 2019, economist Dr. Kristina Acri argues against importation, concluding: “Diverting drugs meant for Canadian patients to the U.S. through state importation schemes will create shortages for Canadian patients and increase pressure on potentially unscrupulous suppliers to source drugs from wherever they can, opening the door to counterfeiters.”

[...]

The Wall Street Journal’s Editorial Board Comes Out Against Drug Importation

The editorial board of the The Wall Street Journal published this editorial on April 15, 2019. In it, they write:

“The argument that drug importation threatens the integrity of the drug supply is often dismissed because pharmaceutical lobbyists make it. But keeping the drug supply free from contaminated or counterfeit products is not easy, and the World Health Organization has warned that 1 in 10 medical products in the developing world are phony. It isn’t clear who is liable if counterfeits are found in Florida, but you can bet it won’t be the politicians.”

[...]

Vermont: Still #1 in Dumb Healthcare Ideas

Earlier this month, in the midst of an opioid epidemic ravaging the state, Vermont’s legislature voted to legalize buying drugs from Canada, where government-set price controls keep prices artificially low.

[...]